Added to YB: 2025-04-11
Pitch date: 2025-04-09
PHX.AX [neutral]
PharmX Technologies Limited
+86.67%
current return
Author Info
Kreuzmann Investing is looking for the best opportunities in Small and Microcap companies around the world. Sign up for the newsletter.
Company Info
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia.
Market Cap
AUD 77.8M
Pitch Price
AUD 0.07
Price Target
N/A
Dividend
N/A
EV/EBITDA
144.15
P/E
-294.78
EV/Sales
9.90
Sector
Software
Category
growth
Updates On My Down Under Stocks - PharmX Technologies & Connexion Mobility
PHX.AX (holding update): Modernizing Australian pharmacies via monopolistic EDI solution. Expanding into marketplace, data analytics, and NZ. Strong partnerships (MCO Beauty, Phillip Morris). 10% EDI growth potential, $50m ARR target. Competitor Directo can be shut down. High-margin business with 50% EBITDA potential. Risks: execution, GM contract renewal.
Read full article (18 min)